Notification of cessation of securities - MYX
Released
Released
Announcement PDF
Appendix 3H - Notification of cessation of securities
Announcement Summary
Entity name
MAYNE PHARMA GROUP LIMITED
Announcement Type
New announcement
Date of this announcement
Wednesday January 15, 2025
Details of +securities that have ceased
ASX +security
code
Security description
MYXAN
PERFORMANCE RIGHTS
Number of
+securities that
have ceased
2,392
The +securities have
ceased due to
Date of
cessation
Lapse of conditional right to
securities because the
conditions have not been, or
have become incapable of
being, satisfied
13/01/2025
Refer to next page for full details of the announcement
Appendix 3H - Notification of cessation of securities
1/4
Appendix 3H - Notification of cessation of securities
Part 1 - Announcement Details
1.1 Name of +Entity
MAYNE PHARMA GROUP LIMITED
We (the entity named above) provide the following information about our issued capital.
1.2 Registered Number Type
Registration Number
ABN
76115832963
1.3 ASX issuer code
MYX
1.4 The announcement is
New announcement
1.5 Date of this announcement
15/1/2025
Appendix 3H - Notification of cessation of securities
2/4
Appendix 3H - Notification of cessation of securities
Part 2 - Details of +equity securities or +debt securities that have ceased
ASX +Security Code and Description
MYXAN : PERFORMANCE RIGHTS
Unquoted +equity securities that have ceased
Number of securities that have ceased
2,392
Reason for cessation
Lapse of conditional right to securities because the conditions have not been, or have become incapable of being,
satisfied
Date of cessation
13/1/2025
Is the entity paying any consideration for the cessation?
No
Any other information the entity wishes to notify to ASX about the cessation?
2,392 RSU performance rights lapsed in accordance with Mayne Pharma's Employee Performance Rights and Option
Plan
Appendix 3H - Notification of cessation of securities
3/4
Appendix 3H - Notification of cessation of securities
Part 3 - Issued capital following changes
Following the cessation of the +securities the subject of this notification, the issued capital of the entity will
comprise:
The figures in parts 3.1 and 3.2 below are automatically generated and may not reflect the entity's current issued capital if
other Appendix 2A, Appendix 3G or Appendix 3H forms are currently with ASX for processing.
3.1 Quoted +equity securities and +debt securities (total number of each +class of +securities quoted on ASX)
ASX +security code and description
MYX : ORDINARY FULLY PAID
Total number of
+securities on issue
81,245,827
3.2 Unquoted +equity securities (total number of each +class of +equity securities issued but not quoted on ASX)
ASX +security code and description
Total number of
+securities on issue
MYXAA : CONVERTIBLE NOTES
27,950
MYXAN : PERFORMANCE RIGHTS
5,923,936
MYXAT : OPTION EXPIRING VARIOUS DATES EX VARIOUS PRICES
695,322
Note: the figures stated in the tables above are used to calculate the total market capitalisation of the entity published by
ASX from time to time. The table will not include those classes of +securities that have ceased or lapsed in their entirety in
ASX records before the announcement date described in Q1.5, even if the entity has advised ASX of a change to that class
of +security in Part 2 of this form.
Appendix 3H - Notification of cessation of securities
4/4
Share your feedback
Discover